Surgical Oncologist
General Surgery
Dr. Lawrence A. Shirley, MD
|
|
Give Review
Lawrence Shirley works in the field of General Surgery. He went to medical school at University of Kentucky College of Medicine. University of Kentucky College of Medicine is ranked 63 in research and 72 in primary care medicine He has 1 awards "Fellow (FACS)". Dr. Lawrence A. Shirley is also published. He has 19 publications published. The lastest publication: "Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target.'
Publications
- Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target.
- Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes.
- Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma.
- Outcomes in Patients with Obstructive Jaundice from Metastatic Colorectal Cancer and Implications for Management.
- An indeterminate nodule in the cirrhotic liver discovered by surveillance imaging is a prelude to malignancy.
- Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.
- Microwave Ablation for Hepatic Malignancies: A Multiinstitutional Analysis.
- Acinar Cell Cystadenoma of the Pancreas: Report of Three Cases and Literature Review.
- ErbB2 induces Notch1 activity and function in breast cancer cells.
- Therapeutic endoscopic ultrasonography: intratumoral injection for pancreatic adenocarcinoma.
- The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion.
- p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo.
- Single-cell transcription site activation predicts chemotherapy response in human colorectal tumors.
- Inhibition of cyclin D1 gene transcription by Brg-1.
- Sirtuins, nuclear hormone receptor acetylation and transcriptional regulation.
- The functional significance of nuclear receptor acetylation.
- The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
- Alternative cyclin D1 splice forms differentially regulate the DNA damage response.
Schools
University Of Kentucky
Doctors Specialties
- Complex General Surgical Oncology
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Ohio State University Hospital -
Thomas Jefferson University -
University of Kentucky College of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Alexander E. Poor, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret L. Crivello, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alina M. Mateo, MD |
|
|
Dr. John S. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin J. O'Sullivan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nandini N. Kulkarni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane Y. Hui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah J. Mathew, MD |
|
Dr. Jeffrey M. Farma, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Steven B. Standiford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James L. Mullen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert G. Somers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcia C. Boraas, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Paul G. Curcillo II, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|